Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00436475 · ClinicalTrials.gov registry record · Phase 1
Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
A Phase 1 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 92
- Enrollment target
NCT00436475 is a Phase 1 study that has completed, run by Tufts Medical Center. The registered enrollment target is 92 participants.
The verdict
NCT00436475, a Phase 1 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of the randomized trial is to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for type 2 diabetes.
Interventions
- DRUG Vitamin D3 2,000 IU orally once daily
- DRUG Calcium Carbonate 400 mg orally twice daily
- DRUG Vitamin D3-Placebo
- DRUG Calcium-Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00436475
The ClinicalTrials.gov registry entry for NCT00436475 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vitamin D3 2,000 IU orally once daily is the first listed.
NCT00436475 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00436475 about?
NCT00436475 is a clinical study titled "Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes". The purpose of the randomized trial is to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for type 2 diabetes.
What is the current status of trial NCT00436475?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 92 participants. The study started on 2007-09. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00436475?
The interventions under investigation include: Vitamin D3 2,000 IU orally once daily (DRUG), Calcium Carbonate 400 mg orally twice daily (DRUG), Vitamin D3-Placebo (DRUG), Calcium-Placebo (DRUG).
Who is sponsoring clinical trial NCT00436475?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.